Trends in ophthalmic antimicrobial utilization pattern in Bahrain between 1993 and 2000: A resurgence of chloramphenicol?

International Journal of Clinical Pharmacology and Therapeutics

Volumn 41, Issue 1, 2003, Pages 36-41

  Al Khaja, K A Jassim ^a   Sequeira, R P ^a   Mathur, V S ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Chloramphenicol; Drug cost; Drug procurement; Drug utilization; Ophthalmic antimicrobials

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; CHLORAMPHENICOL; DEXAMETHASONE; EYE DROPS; EYE OINTMENT; FRAMYCETIN; FUSIDIC ACID; GENTAMICIN; GRAMICIDIN; NEOMYCIN; OXYTETRACYCLINE; POLYMYXIN B; POLYMYXIN DERIVATIVE; SULFACETAMIDE;

ANTIBIOTIC RESISTANCE; APLASTIC ANEMIA; ARTICLE; BAHRAIN; CONTROLLED STUDY; DRUG COST; DRUG MARKETING; DRUG SAFETY; DRUG USE; EYE INFECTION; HUMAN; MEDICAL SPECIALIST; OPHTHALMOLOGY; PATIENT CARE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT;

EID: 0037231695     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/cpp41036     Document Type: Article

References (44)

1. Abrams SM, Degnan TJ, Vineiguerra V 1980 Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Inter Med 140:576-577
2. Anonymous 1993 How to investigate drug use in health facilities. Selected drug use indicators. WHO, Geneva
3. Aragones JV, Erikson SP 1968 Stable chloramphenicol solution for ocular infections. Am J Ophthalmol 66: 104-106
4. Beasley H, Boltralik JJ, Baldwin HA 1975 Chloramphenicol in aqueous humor after topical application. Arch Ophthalmol 93: 184-185
5. Best WR 1967 Chloramphenicol-associated blood dyscrasias. A review of cases submitted to the American Medical Association Registry. J Am Med Assoc 201: 181-188
6. British National Formulary (BNF) 2001 (No.: 41 March) British Medical Association and Royal Pharmaceutical Society of Great Britain, London, 459-460
7. Brodsky E, Zeidan Z, Biger Y, Schneider M 1989 Topical application of chloramphenicol eye ointment followed by fatal bone marrow aplasia. Isr J Med Sci 25: 54
8. Buckley SA 1990 Survey of patients taking topical medication at their first presentation to eye casualty. Br Med J 300: 1497-1498
9. Carpenter G 1975 Chloramphenicol eye drops and marrow aplasia. Lancet II: 326-327
10. Cox J, Roderick EM 1995 Is it time to stop using chloramphenicol on the eye? General practitioners would expect to see aplasia roughly once each century. Br Med J 311: 451
11. Doona M, Walsh JB 1995a Is it time to stop using chloramphenicol on the eye? Br Med J 311: 451
12. Doona M, Walsh JB 1995b Use of chloramphenicol as topical eye medication: time to cry halt? Br MedJ 310: 1217-1218
13. Doona M, Walsh JB 1998 Topical chloramphenicol is an outmoded treatment. Br Med J 316: 1903
14. Dutro MP 1981 Chloramphenicol and aplastic anemia. Am J Ophthalmol 92: 870-871
15. Field D, Martin D, Witchell L 1999 Ophthalmic chloramphenicol: a review of the literature. Accid Emerg Nurs 7: 13-17
16. Fraunfelder FT, Bagby GC, Kelly DJ 1982 Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 93: 356-360
17. Fraunfelder FT, Morgan RL, Yunis AA 1993 Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol 115: 812-813
18. Gordon-Smith EC, Marsh JCW, Geary CG 1995 Is it time to stop using chloramphenicol on the eye? Prospective study of aplastic anemia should give definitive answer. Br Med J 311: 451
19. Hall AV, Das SS, Tabaqchali S 1995 Is it time to stop using chloramphenicol on the eye? Risk is low in short courses. Br Med J 311: 450-451
20. Hanna C, Massey JY, Hendrickson RO, Williamson J, Jones EM, Wilson P 1978 Ocular penetration of chloramphenicol. Arch Ophthalmol 96: 1258-1261
21. Hogerzeil HV, Walker GJA, Sallami AO, Fernando G 1989 Impact of an essential drugs programme on availability and rational use of drugs. Lancet I: 141-142
22. Issaragrisil S, Piankijagum A 1985 Aplastic anemia following topical administration of ophthalmic chloramphenicol. Report of a case and review ofliterature. J Med Assoc Thailand 68: 309-312
23. Lancaster T, Swart AM, Jick H 1998 Risk of serious hematological toxicity with use of chloramphenicol eye drops in a British general practice database. Br Med J 316: 667
24. Laporte JR, Vidal X, Ballarin E, Ibanez I 1998 Possible association between ocular chloramphenicol and aplastic anemia - the absolute risk is very low. Br J Clin Pharmacol 46: 181-184
25. Leibowitz HM 2000 The red eye. N Engl J Med 343: 345-351
26. Mauger TF 1994 Antimicrobials. In: Mauger TF, Craig EL (eds): Harvener's ocular pharmacology. Mosby, St Louis: 274-278
27. McGhee CNJ, Anastas CN 1996 Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anemia? Br J Ophthalmol 80: 182-184
28. Melmon KL, Nierenberg DW 1981 Drug interactions and the prepared observer. N Engl J Med 304: 723
29. Mulla RJ, Barnes E, Rogers TR 1995 Is it time to stop using chloramphenicol on the eye? Fears are based on only six cases. Br Med J 311: 450
30. Nagac T, Mauer AM 1969 Concordance for drug-induced aplastic anemia in identical twins. N Engl J Med 281: 7-11
31. Oski FA 1979 Hematological consequences of chloramphenicol therapy. J Pediatr 94: 515-516
32. Physicians' Desk Reference (PDR) 2000 (54th ed) Medical Economic Company, Philadelphia
33. Rayner SA, Buckley RJ 1996 Ocular chloramphenicol and aplastic anemia: is there a link? Drug Saf 14: 273-276
34. Reeves DS, Finch RG, Bax RP et al 1999 Self-medication of antibacterials without prescription (also called "over-the-counter" use): a report ofa Working Party of British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 44: 163-177
35. Rich ML, Ritterhoff RJ, Hoffman RJ 1950 A fatal case of aplastic anemia following chloramphenicol therapy. Ann Intern Med 33: 1459-1467
36. Rosenthal RL, Blackman A 1965 Bone marrow hypoplasia following use of chloramphenicol eye drops. J Am Med Assoc 191: 148-149
37. De Sevilla TF, Alegre J, Vallespi T, Falco V Martinez-Vazquez JM 1990 Adult pure red cell aplasia following topical ocular chloramphenicol. Br J Ophthalmol 74: 640
38. Tan LK 1999 Chloramphenicol-induced aplastic anemia -should its topical use be abandoned? Singapore Med J 40: 445-446
39. Titcomb L 1997 Ophthalmic chloramphenicol and blood dyscrasias - a review. Pharm J 258: 28-35
40. Ursell P 1996 Widespread use of topical chloramphenicol. Br J Ophthalmol 80: 854
41. Walker S, Diaper CJ, Bowman R et al 1998 Lack of evidence for systemic toxicity following topical chloramphenicol. Eye 12: 875-879
42. Wiholm BE, Kelly JP, Kaufman D et al 1998 Relation of aplastic anemia to use of chloramphenicol eye drops in two international case-control studies. Br Med J 316: 666
43. Yunis AA 1973 Chloramphenicol-induced bone marrow suppression. Semin Hematol 10: 225-234
44. 2 in aplastic anemia. Clin Toxicol 17: 359-373